This document provides specific guidance for screening and post- screening management of all people who have been identified through public health investigations as having been exposed to multidrug resistant tuberculosis (MDR TB). Recommendations for symptomatic contacts, children less than 5 years of age and those who are highly immunocompromised (see step 1B) are different from other groups.
Audiences:
Persons with TB
Focus Area:
TB
Subjects:
TB Treatment
Publication Date:
2018
Format:
Guideline
Last Updated Date:
Publication ID:
365081